Clinical Trial Update: Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating metformin as add-on therapy to standard treatment for pulmonary arterial hypertension (grade II/III) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Nantes University Hospital | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: WITHDRAWN